Estrogen deficiency caused by ovariectomy (OVX) induces bone loss and increased B-lymphopoiesis in bone marrow. In OVX mice, the production of prostaglandin E (PGE) and the expression of receptor activator of nuclear factor-κB ligand (RANKL) were elevated in osteoblasts, and the cell adhesion of B cells induced RANKL expression in osteoblasts. However, the roles of PGE in RANKL expression and bone resorption are not clear. To examine the relationship between B-lymphopoiesis and PGE production by osteoblasts, B cells were purified from bone marrow, fixed, and co-cultured with mouse osteoblasts. Most of the fixed B cells adhered to cell surface of osteoblasts, and the cell-cell interaction markedly elevated the expression of cyclooxygenase (COX)-2 and membrane-bound PGE synthase (mPGES)-1 mRNAs, and PGE 2 production in osteoblasts. Adding B cells also induced the expression of RANKL mRNA in osteoblasts, and the RANKL expression was suppressed by indomethacin, COX-2 inhibitor (NS398) and selective antagonist for PGE receptor EP4, suggesting that PGE production and EP4 signals are involved in RANKL-dependent bone resorption induced by cell-cell contact between B cells and osteoblasts. Therefore, the increased B-lymphopoiesis and PGE production by osteoblasts may contribute to the pathogenesis of osteoporosis due to estrogen deficiency.
INTRODUCTION
Postmenopausal osteoporosis is characterized by decreased bone mass due to the elevation of bone resorption. OVX animals have been used to understand the mechanism of bone loss due to estrogen deficiency. We have reported that OVX mice exhibited the marked stimulation of bone marrow B-lymphopoiesis, resulting in an accumulation of B cells in mouse bone marrow, and that the treatment of estrogen recovered both bone mass and B-lymphopoiesis to normal levels in OVX mice. 1) In addition, the increased B-lymphopoiesis by the administration of interleukin-7 (IL-7) resulted in marked bone loss caused by stimulated bone resorption in mice with intact ovarian function. 2) Boneresorbing cytokines such as IL-1, IL-6 and tumor necrosis factor α may have been reported to a possible factor(s) in the pathogenesis of osteoporosis, but the mechanism of bone loss in OVX mice is still controversial. [3] [4] [5] As a pivotal factor in osteoclast differentiation, previous studies have identified the receptor activator of nuclear factor-κB ligand (RANKL), which is expressed on the cell surface of osteoblasts in response to bone-resorbing factors. [6] [7] [8] [9] Osteoclast precursors possess RANK, a receptor for RANKL, and can differentiate into mature osteoclasts via a mechanism of RANK-RANKL recognition.
Prostaglandin E 2 (PGE 2 ) is a typical boneresorbing factor involved in bone loss associated with inflammation. We have reported that boneresorbing cytokines such as IL-1 and IL-6 are known to induce PGE 2 production by osteoblasts, and the produced PGE 2 stimulates adenylate cyclase to accumulate cellular cAMP in osteoblasts, which induces the expression of RANKL for osteoclast differentiation through its receptor sub-type EP4. 10, 11) PGE synthesis is regulated by three metabolic steps; the release of arachidonic acid from the membranous phospholipids by phospholipase A 2 (PLA 2 ), the conversion of arachidonic acid to PGH 2 by cyclooxygenase (COX) and the synthesis of PGE 2 by PGE synthase (PGES). [12] [13] [14] We have reported that the purpose of cytosolic PLA 2 (cPLA 2 ) expression in osteoblasts is to release arachidonic acid following PGE 2 production, and that the expression of membrane-bound PGE synthase (mPGES)-1 is markedly induced by inflammatory stimuli, and functionally coupled with COX-2. 15, 16) The coordinate induction of COX-2 and mPGES-1 is essential for PGE 2 production by osteoblasts.
We previously reported that both PGE 2 production and RANKL expression was elevated in osteoblasts and bone marrow in OVX mice. 17, 18) However, the roles of PGE in RANKL expression and bone resorption are not clear. In the present study, we show that PGE 2 produced by cell-to-cell interaction between B-lymphocytes and osteoblasts markedly induce RANKL expression in osteoblasts, suggesting a possible role of B-lymphopoiesis and PGE 2 in bone loss due to estrogen deficiency.
MATERIALS AND METHODS
Animals and Reagents --DdY mice, day 2, 6-weeks and 8-weeks of age, were obtained from Japan SLC (Shizuoka, Japan). Eight-week-old mice were either sham-operated or OVX. All procedures were performed in accordance with institutional guideline for animal research. Indomethacin and NS398 (an inhibitor of COX-2) were purchased from Calbiochem (San Diego, CA, U.S.A.). EP4 antagonist (ONO-AE2-227) was provided by Ono Pharmaceutical Co., Ltd (Osaka, Japan). Radiographic Analysis of the Femur --The bone mineral density (BMD) of the femurs collected from sham-operated or OVX mice were measured by dual X-ray absorptiometry (model DCS-600R; Aloka, Tokyo, Japan). 2) The bone mineral content (BMC) of the mouse femur was closely correlated with the ash weight. The BMD was calculated by dividing the BMC of the measured area by the area. The scanned area was dividing equally into three regions comprising the proximal, middle and distal femur to assess regional differences. Flow Cytometric Analysis --Bone marrow cells (2 × 10 6 ) were obtained from sham-operated or OVX mice 2 week after surgery, and incubated with fluorescein isothiocyanate (FITC)-conjugated B220 (RA3-6B2; Pharmingen, San Diego, CA, U.S.A.), as described previously. 1) These cells were washed with phosphate-buffered saline (PBS) (−) containing 1% bovine serum albumin (BSA) and analyzed on a flow cytometer (FACScalibur, Becton Dickinson, San Jose, CA, U.S.A.). Isolation of Bone Marrow B-lymphocytes --Bone marrow cells were prepared from the tibiae and femora of 6-week-old mice, centrifuged and resuspended in 2 ml of ammonium chloride-Tris buffer to lyse red blood cells. The cell suspension was washed, and isolated from bone marrow with a magnetic cell-sorting (MACS) system using magnetic micro-beads coated with anti-mouse CD45R/B220 (Pharmingen). 18) The isolated B cells were more than 98% positive to B220 in flow cytometric analysis. Co-culture of Mouse Osteoblasts and B-lymphocytes --Primary osteoblasts were isolated from 2-day-old mouse calvariae after five routine sequential digestions with 0.1% collagenase (Wako Pure Chemical Industries (Osaka, Japan)) and 0.2% dispase (Godo Shusei, Tokyo, Japan). Osteoblasts were cultured in α-modified minimum essential medium (αMEM) supplemented with 10% fetal calf serum (FCS) at 37 • C under 5% CO 2 in air. Isolated B-lymphocytes were fixed with 4% paraformaldehyde, washed three times with PBS (−) and added to the cell layer of mouse osteoblasts, and cultured until 24 hr. RT-PCR Analysis --Total RNA was extracted from mouse osteoblasts using the acid guanidiumphenol-chloroform method. cDNA was synthesized from 5 µg of total RNA by reverse transcriptase (Superscript II Preamplification System, Invitrogen, Carlsbad, CA, U.S.A.) and amplified via PCR. The primers in PCR for mouse COX-1, COX-2, mPGES-1, RANKL, and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) genes were used as reported previously. 15, 16) The PCR product was run on a 1.5% agarose gel and stained with ethidium bromide. The signals were densitometrically quantified using an National Institutes of Health (NIH)-image analyzer. Measurement of PGE 2 Content --The concentrations of PGE 2 in the cultured medium were determined using an enzyme immunoassay (EIA; Amersham Biosciences). The antibody had the following cross-reactivity when calculated by the bound/free ratio: PGE 2 , 100%; PGE 1 , 70%; 6-keto-PGF 1 α, 5.4%; PGF 2 α, 4.3%; and PGD 2 , 1.0%. Statistical Analysis --The data are expressed as means ± standard error of the mean (SEM). The significance of differences was analyzed using Student's t-test. Figure 1 shows the influence of OVX on femoral bone mass and fluorescence activated cell sorter (FACS) analysis of bone marrow B cells. OVX mice showed a significant decrease in femoral BMD, and an increased number of bone marrow B cells 2-4 weeks after surgery (Fig. 1) . The expression of B220 in the B-cell lineage is developmentally regulated, and immature pre-B cells was weakly stained with B220 antibody, whereas mature B cells showed the intense staining. In FACS analysis, we detected two peaks of B cells, peak I (pre-B cells) and peak II (mature B cells), in sham-operated mice. In OVX mice, the percentage of B cells was elevated, and major peak of B cells was peak I, indicating that estrogen loss induces the accumulation of immature B cells in bone marrow (Fig. 1B) . Levels of PGE 2 in bone marrow supernatant in OVX mice were higher than those in sham mice (sham: 2.4 ± 1.1 ng/ml; OVX: 5.0 ± 0.8 ng/ml), suggesting a possible role of PGE produced by bone and bone marrow in bone resorption due to estrogen deficiency.
RESULTS

Bone Loss and Increased B-lymphopoiesis in OVX Mice
Expression of COX-2 and mPGES-1 mRNAs and PGE 2 Production in Osteoblasts by the Contact with Fixed B-lymphocytes
We have reported that B-lymphocytes induces the expression of RANKL in osteoblasts via cell adhesion. 18 ) Then, we examined the possible role of B cells in PGE 2 production by osteoblasts. B cells were purified from mouse bone marrow using B220-conjugated magnetic microbeads, and fixed with paraformaldehyde to avoid PGE 2 production by B cells. Most fixed-B cells attached to osteoblast surfaces 24 hr after the addition. The expression of COX-2 and mPGES-1 mRNAs was markedly induced in osteoblasts after the addition of fixed B cells, and the level of PGE 2 was elevated in the conditioned medium of the co-cultures of osteoblasts and fixed-B cells (Fig. 2) . In contrast, the expression of COX-1 mRNA was suppressed by adding fixed B cells. The expression of COX-2 and mPGES-1 mRNAs could not be elevated in osteoblasts in the separate co-cultures (data not shown), indicating that cell-to-cell contact with B cells is essential for induction of PGE 2 production by osteoblasts.
Relationship between PGE 2 Production and RANKL Expression in Osteoblasts
To examine the relationship between PGE 2 production and RANKL expression in osteoblasts after cell-to-cell contact with B cells, indomethacin, NS398 (an inhibitor of COX-2) and EP4 antagonist were added to the co-cultures of osteoblasts and fixed-B cells. As shown in Fig. 3 , the cell-tocell contact with B cells significantly induced the expression of RANKL mRNA in osteoblasts, and these inhibitors significantly suppressed the expression of RANKL mRNA in osteoblasts 24 hr after the contact with fixed-B cells. Therefore, PGE 2 production and EP4-mediated signals may be involved in the mechanism of RANKL expression in osteoblasts. 
DISCUSSION
PGE 2 is a typical inducer of bone resorption associated with inflammation. We have reported that PGE 2 binds to the EP4 receptor, one of the PGE receptor subtypes EP1-EP4, and induces RANKL expression to stimulate bone resorption, using agonist and antagonist of EPs and respective EP-knockout mice. 11) In the present study, the cell-to-cell contact with fixed-B cells markedly induced the expression of COX-2 and mPGES-1 and PGE 2 production in osteoblasts. The cell-to-cell contact with B cells also induced RANKL expression in osteoblasts, and the RANKL expression was completely suppressed by adding inhibitors of PGE 2 production and EP4 antagonist. Therefore, PGE 2 produced by osteoblasts after the cell-to-cell contact with B cells binds to EP4, and induces RANKL expression via Vol. 55 (2009) EP4-mediated signals (Fig. 4) .
Using mPGES-1 null mice, we have reported that mPGES-1 is essential for PGE synthesis in osteoblasts treated with bone resorbing cytokine, and RANKL-dependent osteoclast formation could not be induced by IL-1 in mPGES-1 null mice. 16) It is well known that the induction of COX-2 is essential for PGE 2 synthesis induced by various stimuli. Therefore, the coordinate induction of COX-2 and mPGES-1 is critical for PGE 2 production by osteoblasts treated with various stimuli. Previous studies have shown that the mouse COX-2 gene promoter possesses functional regulatory elements for NFκB and AP-1. 19) In contrast, the mouse mPGES-1 gene promoter possesses AP-1, but not NFκB. 20) In the present study, the cell-to-cell contact with B cells induced the expression of COX-2 and mPGES-1 in osteoblasts, but the expression of COX-1 was suppressed by the contact with B cells. Osteoblasts are known to express various integrins such as α1, αv, and β1, and adhesion signals are involved in the activation of several kinases and NFκB. 21) Recently, cell adhesion has been shown to regulate intracellular key mediators including LFA-1, VLA-4, Focal adhesion kinase (FAK), MAPKK/ERK kinase (MEK), Rho kinase, and NFκB in the field of cancer. 22) We have reported that osteoblasts produce PGE 2 after the cell-to-cell contact with cancer cells by the induction of COX-2, and that the PGE 2 production is involved in the mechanism of osteolysis due to bone metastasis. 23) Further studies are needed to define a possible adhesion molecule(s) involved in the cell-to-cell contact between B cells and osteoblasts to induce COX-2 and mPGES-1 genes. In addition, the mechanism of regulation of COX-1 and COX-2 after the cell-to-cell contact is the question to define in the future study.
It is well known that RANKL is a pivotal factor in osteoclast differentiation, and that bone loss due to estrogen deficiency is caused by increased osteoclastic bone resorption. Ikeda et al. have reported that the expression of RANKL mRNA was detected in femoral primary spongiosa in OVX rats but not in sham-operated rats. 24) Recently, Li et al. have shown that both B cells and T cells are critical for bone mass in vivo, using B cell knockout mice and T-cell-deficient nude mice. 25) We have detected the increased expression of RANKL mRNA in bone and bone marrow in OVX mice. 18) In the present study, we showed that RANKL expression in osteoblasts could be induced by PGE 2 after cell adhesion to bone marrow B cells. Therefore, the interaction between osteoblasts and bone marrow B-lymphocytes may contribute to the pathogenesis of bone loss due to estrogen deficiency.
